SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Norris Medicines submits standalone un-audited financial results

06 Feb 2020 Evaluate

Pursuant to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Norris Medicines has informed about submission of Standalone Un-audited Financial Results of the Company for the Quarter and nine month ended on 31st December, 2019; and Limited Review Report by Statutory Auditors on Standalone Un-audited Financial Results for the quarter and nine month ended on 31st December, 2019.

The above information is a part of company's filings submitted to BSE.

Norris Medicines Share Price

14.00 0.50 (3.70%)
19-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1837.15
Dr. Reddys Lab 1271.55
Cipla 1353.85
Zydus Lifesciences 1070.90
Lupin 2351.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: